Terms: = Pancreatic cancer AND MAF, MGC71685, 4094, ENSG00000178573
28 results:
1. Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer.
Raymant M; Astuti Y; Alvaro-Espinosa L; Green D; Quaranta V; Bellomo G; Glenn M; Chandran-Gorner V; Palmer DH; Halloran C; Ghaneh P; Henderson NC; Morton JP; Valiente M; Mielgo A; Schmid MC
Nat Commun; 2024 Apr; 15(1):3593. PubMed ID: 38678021
[TBL] [Abstract] [Full Text] [Related]
2. High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study.
Huang L; Lv Y; Guan S; Yan H; Han L; Wang Z; Han Q; Dai G; Shi Y
J Transl Med; 2024 Feb; 22(1):184. PubMed ID: 38378604
[TBL] [Abstract] [Full Text] [Related]
3. Short-term serial circulating tumor DNA assessment predicts therapeutic efficacy for patients with advanced pancreatic cancer.
Motobayashi H; Kitahata Y; Okada KI; Miyazawa M; Ueno M; Hayami S; Miyamoto A; Shimizu A; Sato M; Yoshimura T; Nakamura Y; Takemoto N; Nakai T; Hyo T; Matsumoto K; Yamaue H; Kawai M
J Cancer Res Clin Oncol; 2024 Jan; 150(2):35. PubMed ID: 38277079
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA mafG-AS1 is involved in human cancer progression.
Li P; Ma X; Gu X
Eur J Med Res; 2023 Nov; 28(1):497. PubMed ID: 37941063
[TBL] [Abstract] [Full Text] [Related]
5. Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians.
Piccardi M; Gentiluomo M; Bertoncini S; Pezzilli R; Erőss B; Bunduc S; Uzunoglu FG; Talar-Wojnarowska R; Vanagas T; Sperti C; Oliverius M; Aoki MN; Ermini S; Hussein T; Boggi U; Jamroziak K; Maiello E; Morelli L; Vodickova L; Di Franco G; Landi S; Szentesi A; Lovecek M; Puzzono M; Tavano F; van Laarhoven HWM; Zerbi A; Mohelnikova-Duchonova B; Stocker H; Costello E; Capurso G; Ginocchi L; Lawlor RT; Vanella G; Bazzocchi F; Izbicki JR; Latiano A; Bueno-de-Mesquita B; Ponz de Leon Pisani R; Schöttker B; Soucek P; Hegyi P; Gazouli M; Hackert T; Kupcinskas J; Poskiene L; Tacelli M; Roth S; Carrara S; Perri F; Hlavac V; Theodoropoulos GE; Busch OR; Mambrini A; van Eijck CHJ; Arcidiacono P; Scarpa A; Pasquali C; Basso D; Lucchesi M; Milanetto AC; Neoptolemos JP; Cavestro GM; Janciauskas D; Chen X; Chammas R; Goetz M; Brenner H; Archibugi L; Dannemann M; Canzian F; Tofanelli S; Campa D
Biol Res; 2023 Aug; 56(1):46. PubMed ID: 37574541
[TBL] [Abstract] [Full Text] [Related]
6. Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected pancreatic Ductal Adenocarcinomas.
Leick KM; Tomanek-Chalkley A; Coleman KL; Chan CHF
Ann Surg Oncol; 2023 Oct; 30(11):6652-6660. PubMed ID: 37303025
[TBL] [Abstract] [Full Text] [Related]
7. FALCON systematically interrogates free fatty acid biology and identifies a novel mediator of lipotoxicity.
Wieder N; Fried JC; Kim C; Sidhom EH; Brown MR; Marshall JL; Arevalo C; Dvela-Levitt M; Kost-Alimova M; Sieber J; Gabriel KR; Pacheco J; Clish C; Abbasi HS; Singh S; Rutter JC; Therrien M; Yoon H; Lai ZW; Baublis A; Subramanian R; Devkota R; Small J; Sreekanth V; Han M; Lim D; Carpenter AE; Flannick J; Finucane H; Haigis MC; Claussnitzer M; Sheu E; Stevens B; Wagner BK; Choudhary A; Shaw JL; Pablo JL; Greka A
Cell Metab; 2023 May; 35(5):887-905.e11. PubMed ID: 37075753
[TBL] [Abstract] [Full Text] [Related]
8. Insulinomatosis: new aspects.
Christ E; Iacovazzo D; Korbonits M; Perren A
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36952647
[TBL] [Abstract] [Full Text] [Related]
9. A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma.
van Eijck CWF; de Koning W; van der Sijde F; Moskie M; Groot Koerkamp B; Homs MYV; van der Burg SH; van Eijck CHJ; Mustafa DAM
Eur J Cancer; 2023 Mar; 181():119-134. PubMed ID: 36652890
[TBL] [Abstract] [Full Text] [Related]
10. KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence.
Amintas S; Fernandez B; Chauvet A; Chiche L; Laurent C; Belleannée G; Marty M; Buscail E; Dabernat S
Sci Rep; 2022 Feb; 12(1):2976. PubMed ID: 35194118
[TBL] [Abstract] [Full Text] [Related]
11. Targeted Transcriptome and
Lundy J; Gao H; Berry W; Masoumi-Moghoddam S; Jenkins BJ; Croagh D
Clin Cancer Res; 2021 Nov; 27(21):5900-5911. PubMed ID: 34400416
[TBL] [Abstract] [Full Text] [Related]
12. Functional analysis of large maf transcription factors and elucidation of their relationships with human diseases.
Takahashi S
Exp Anim; 2021 Aug; 70(3):264-271. PubMed ID: 33762508
[TBL] [Abstract] [Full Text] [Related]
13. Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy.
Sugimori M; Sugimori K; Tsuchiya H; Suzuki Y; Tsuyuki S; Kaneta Y; Hirotani A; Sanga K; Tozuka Y; Komiyama S; Sato T; Tezuka S; Goda Y; Irie K; Miwa H; Miura Y; Ishii T; Kaneko T; Nagahama M; Shibata W; Nozaki A; Maeda S
Cancer Sci; 2020 Jan; 111(1):266-278. PubMed ID: 31746520
[TBL] [Abstract] [Full Text] [Related]
14. Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease.
Filippini D; Agosto S; Delfino P; Simbolo M; Piro G; Rusev B; Veghini L; Cantù C; Lupo F; Ugel S; De Sanctis F; Bronte V; Milella M; Tortora G; Scarpa A; Carbone C; Corbo V
Sci Rep; 2019 Aug; 9(1):12286. PubMed ID: 31439856
[TBL] [Abstract] [Full Text] [Related]
15. Prediction of new targets and mechanisms for quercetin in the treatment of pancreatic cancer, colon cancer, and rectal cancer.
Pang B; Xu X; Lu Y; Jin H; Yang R; Jiang C; Shao D; Liu Y; Shi J
Food Funct; 2019 Sep; 10(9):5339-5349. PubMed ID: 31393490
[TBL] [Abstract] [Full Text] [Related]
16. Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population.
Suzuki K; Akiyama M; Ishigaki K; Kanai M; Hosoe J; Shojima N; Hozawa A; Kadota A; Kuriki K; Naito M; Tanno K; Ishigaki Y; Hirata M; Matsuda K; Iwata N; Ikeda M; Sawada N; Yamaji T; Iwasaki M; Ikegawa S; Maeda S; Murakami Y; Wakai K; Tsugane S; Sasaki M; Yamamoto M; Okada Y; Kubo M; Kamatani Y; Horikoshi M; Yamauchi T; Kadowaki T
Nat Genet; 2019 Mar; 51(3):379-386. PubMed ID: 30718926
[TBL] [Abstract] [Full Text] [Related]
17. Monitoring Tumor Burden in Response to FOLFIRINOX Chemotherapy Via Profiling Circulating Cell-Free DNA in pancreatic cancer.
Wei T; Zhang Q; Li X; Su W; Li G; Ma T; Gao S; Lou J; Que R; Zheng L; Bai X; Liang T
Mol Cancer Ther; 2019 Jan; 18(1):196-203. PubMed ID: 30301865
[TBL] [Abstract] [Full Text] [Related]
18. Circulating Nucleic Acids Are Associated With Outcomes of Patients With pancreatic cancer.
Bernard V; Kim DU; San Lucas FA; Castillo J; Allenson K; Mulu FC; Stephens BM; Huang J; Semaan A; Guerrero PA; Kamyabi N; Zhao J; Hurd MW; Koay EJ; Taniguchi CM; Herman JM; Javle M; Wolff R; Katz M; Varadhachary G; Maitra A; Alvarez HA
Gastroenterology; 2019 Jan; 156(1):108-118.e4. PubMed ID: 30240661
[TBL] [Abstract] [Full Text] [Related]
19. SPARC gene variants predict clinical outcome in locally advanced and metastatic pancreatic cancer patients.
Arqueros C; Salazar J; Arranz MJ; Sebio A; Mora J; Sullivan I; Tobeña M; Martín-Richard M; Barnadas A; Baiget M; Páez D
Med Oncol; 2017 Aug; 34(8):136. PubMed ID: 28687963
[TBL] [Abstract] [Full Text] [Related]
20. Plasma Circulating Tumor DNA in pancreatic cancer Patients Is a Prognostic Marker.
Pietrasz D; Pécuchet N; Garlan F; Didelot A; Dubreuil O; Doat S; Imbert-Bismut F; Karoui M; Vaillant JC; Taly V; Laurent-Puig P; Bachet JB
Clin Cancer Res; 2017 Jan; 23(1):116-123. PubMed ID: 27993964
[TBL] [Abstract] [Full Text] [Related]
[Next]
